PENTAX Medical Appoints Dr. Klaus Mergener, MD, PhD, MBA as Chief Medical Officer
TOKYO, April 8, 2022 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group, has announced the appointment of Dr. Klaus Mergener, MD, PhD, MBA to the position of Chief Medical Officer of PENTAX Lifecare Division (PENTAX Medical) as of April 1st, 2022. Dr. Klaus Mergener, MD, PhD, MBA, Chief Medical Officer of PENTAX Medical "We are pleased...
CETAPHIL OPTIMAL HYDRATION COMBATS DRY, DEHYDRATED AND SENSITIVE SKIN
Introducing Cetaphil Optimal Hydration, a Hydration Skin Care line that delivers lasting 48-hours hydration KUALA LUMPUR, Malaysia, April 8, 2022 /PRNewswire/ -- Cetaphil is known for its long and proven record of providing skincare solutions with strong dermatological and medical heritage. Delivering only the best to consumers, Cetaphil, a trusted brand for seven decades, is introducing its...
Tianlong COVID-19 Solution Safeguards Passengers In Jakarta International Airport In Indonesia
XI'AN, China, April 8, 2022 /PRNewswire/ -- Tianlong's integrated PCR lab solution is installed in Jakarta's international airport in Indonesia to help conduct nucleic acid testing for inbound and outbound passengers. Since its installation in September 2021, Tianlong's COVID-19 solution has helped diagnose hundreds of positive cases at the Jakarta International Airport. Timely entry testing effectively prevents the import...
AGC to Expand Synthetic Pharmaceutical Production Base in Spain
TOKYO, April 8, 2022 /PRNewswire/ -- AGC Inc. (hereinafter "AGC"), a Tokyo-based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand the facilities of AGC Pharma Chemicals Europe S.L.U. (hereinafter "APCE"), an AGC subsidiary in Spain engaged in the synthetic pharmaceutical (*1) CDMO (*2) business. A new building with a total floor area of 7,500 m2 will be constructed on the company's...
WuXi AppTec Recognized as Top-Rated ESG Company by Sustainalytics
SHANGHAI, April 8, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufacturing services that enables the global pharmaceutical and healthcare industry, received an ESG Risk Rating, recognizing it as a "Top Rated" performing company from Sustainalytics as of March, 2022. WuXi AppTec placed in the top 4 percent of the global pharmaceutical industry with a "Low...
SWISS REJU invests in new body contouring technology, further expands Hong Kong’s beauty and slimming service offerings
HONG KONG, April 8, 2022 /PRNewswire/ -- Wellness and beauty brand SWISS REJU recently announced further investment in new beauty technology, introducing cutting edge, top of the market European slimming machines to the Hong Kong market. SWISS REJU, located at the heart of Central Hong Kong, offers safe and effective body contouring programs for the city's elite clientele, with effective slimming...
New very-high-sensitivity rapid antigen test kits hit Australian market
New COVID-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia MELBOURNE, Australia, April 8, 2022 /PRNewswire/ -- Medriva; https://medriva.com, a leading global manufacturer of COVID-19 testing and vaccination products, announced the Australian availability of its "very-high-sensitivity" Medriva Rapid Antigen Test Kits, following recent approval by the Australian Therapeutic Goods Administration (TGA). With a sensitivity of...
CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer
SHANGHAI and BOSTON, April 7, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies and solid tumors, announces that Dr. Raffaele Baffa ("Dr. Baffa") has been appointed as the Chief Medical Officer ("CMO") of the Company, responsible...
SeekIn Receives CE Mark Approval for LeukoPrint® Molecular Karyotyping Test
First-of-its-Kind Molecular Karyotyping Test SHENZHEN, China, April 7, 2022 /PRNewswire/ -- SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark for LeukoPrint® Molecular Karyotyping Kit and is now ready to launch this test in European markets. Leukemias are a group of life threatening malignant disorders of the blood and...
Henlius’ Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer
SHANGHAI, April 7, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the United States Food and Drug Administration (FDA) has granted Orphan-Drug Designation (ODD) for HANSIZHUANG (serplulimab) for the treatment of small cell lung cancer (SCLC). This is the first such designation granted to HANSIZHUANG. The ODD granted by the FDA is beneficial for the continuous development...
